Treatment of leukemia patients with T101 ricin A chain immunotoxins
- 1 January 1988
- book chapter
- Published by Springer Nature
- Vol. 37, 483-491
- https://doi.org/10.1007/978-1-4613-1083-9_27
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Study of the plasma clearance of antibody – ricin‐A‐chain immunotoxinsEuropean Journal of Biochemistry, 1986
- Biochemical aspects of immunotoxin preparationJournal of Immunological Methods, 1985
- Mouse monoclonal IgG3 antibody detecting GD3 ganglioside: a phase I trial in patients with malignant melanoma.Proceedings of the National Academy of Sciences, 1985
- Optimal elimination of leukemic T cells from human bone marrow with T101-ricin A-chain immunotoxinBlood, 1985
- Therapy of chronic lymphocytic leukemia and cutaneous T-cell lymphoma with T101 monoclonal antibody.Journal of Clinical Oncology, 1984
- Binding of murine immunoglobulin to human tissues after immunotherapy with anticolorectal carcinoma monoclonal antibodyInternational Journal of Cancer, 1984
- Murine monoclonal antibody therapy in two patients with chronic lymphocytic leukemiaBlood, 1982
- Treatment of B-Cell Lymphoma with Monoclonal Anti-Idiotype AntibodyNew England Journal of Medicine, 1982
- RESPONSE OF CUTANEOUS T CELL LYMPHOMA TO THERAPY WITH HYBRIDOMA MONOCLONAL ANTIBODYThe Lancet, 1981
- Serotherapy of acute lymphoblastic leukemia with monoclonal antibodyBlood, 1981